Mark Adame, MD
Family Medicine · Salinas, CANPI 1346245669
Payments from drug & device makers
Across 242 payments — averaging $18.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$805
- GSK$553
- Novo Nordisk$547
- Pfizer$388
- Otsuka America Pharmaceutical, Inc.$313
- AstraZeneca$296
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,588100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $805 |
| GSK | 38 | $553 |
| Novo Nordisk | 20 | $547 |
| Pfizer | 26 | $388 |
| Otsuka America Pharmaceutical, Inc. | 14 | $313 |
| AstraZeneca | 17 | $296 |
| Teva Pharmaceuticals USA, Inc. | 5 | $210 |
| Boehringer Ingelheim | 9 | $155 |
| Lilly USA, LLC | 8 | $153 |
| Mylan Specialty L.p. | 6 | $134 |
| Merck | 4 | $88 |
| Boston Scientific | 5 | $86 |
| Amgen | 4 | $73 |
| Bayer | 3 | $60 |
| Idorsia Pharmaceuticals US Inc | 3 | $58 |
| Verity Pharmaceuticals Inc. | 3 | $55 |
| Lundbeck LLC | 3 | $52 |
| Johnson & Johnson | 3 | $49 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| Sanofi Pasteur Inc. | 2 | $44 |
| Optinose US, Inc. | 2 | $42 |
| Dexcom, Inc. | 2 | $41 |
| Exact Sciences | 2 | $39 |
| Arbor Pharmaceuticals, Inc. | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Embecta Corp. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| Myriad Women's Health, Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Seqirus USA Inc | 1 | $17 |
| Bausch Health US, LLC | 1 | $14 |
| Viatris Specialty LLC | 1 | $14 |
| Genentech USA, Inc. | 1 | $11 |
| Organon | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,588 in reported general payments places this provider in the 90th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 60 | $54,562 |
| MounjaroTirzepatide | 32 | $42,401 |
| OzempicSemaglutide | 39 | $35,644 |
| EliquisApixaban | 26 | $33,606 |
| JanuviaSitagliptin Phosphate | 29 | $19,219 |
| LinzessLinaclotide | 12 | $14,627 |
| Colchicine | 11 | $4,211 |
| Levothyroxine Sodium | 261 | $3,122 |
| Atorvastatin Calcium | 315 | $2,993 |
| SynthroidLevothyroxine Sodium | 29 | $2,350 |
| Pantoprazole Sodium | 193 | $2,218 |
| Rosuvastatin Calcium | 141 | $2,084 |
| Olmesartan Medoxomil | 104 | $2,080 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 72 | $1,813 |
| Metformin Hcl | 193 | $1,609 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $155 | $54,56260 claims |
| Lilly USA, LLCMounjaro | $153 | $42,40132 claims |
| Novo NordiskOzempic | $547 | $35,64439 claims |
| PfizerEliquis | $388 | $33,60626 claims |
| MerckJanuvia | $88 | $19,21929 claims |
| AbbVieLinzess, Synthroid | $805 | $16,97741 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,533 family medicine providers in California.
Other family medicine in Salinas
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.